JP2022512588A5 - - Google Patents

Info

Publication number
JP2022512588A5
JP2022512588A5 JP2021518181A JP2021518181A JP2022512588A5 JP 2022512588 A5 JP2022512588 A5 JP 2022512588A5 JP 2021518181 A JP2021518181 A JP 2021518181A JP 2021518181 A JP2021518181 A JP 2021518181A JP 2022512588 A5 JP2022512588 A5 JP 2022512588A5
Authority
JP
Japan
Prior art keywords
compound
branched
linear
groups
cyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021518181A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022512588A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/054681 external-priority patent/WO2020081257A1/en
Publication of JP2022512588A publication Critical patent/JP2022512588A/ja
Publication of JP2022512588A5 publication Critical patent/JP2022512588A5/ja
Pending legal-status Critical Current

Links

JP2021518181A 2018-10-05 2019-10-04 アルファ1アンチトリプシンのモジュレーター Pending JP2022512588A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862742148P 2018-10-05 2018-10-05
US62/742,148 2018-10-05
US201862768662P 2018-11-16 2018-11-16
US62/768,662 2018-11-16
PCT/US2019/054681 WO2020081257A1 (en) 2018-10-05 2019-10-04 Modulators of alpha-1 antitrypsin

Publications (2)

Publication Number Publication Date
JP2022512588A JP2022512588A (ja) 2022-02-07
JP2022512588A5 true JP2022512588A5 (cg-RX-API-DMAC7.html) 2024-03-12

Family

ID=69467663

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021518181A Pending JP2022512588A (ja) 2018-10-05 2019-10-04 アルファ1アンチトリプシンのモジュレーター

Country Status (16)

Country Link
US (2) US11623924B2 (cg-RX-API-DMAC7.html)
EP (1) EP3860712A1 (cg-RX-API-DMAC7.html)
JP (1) JP2022512588A (cg-RX-API-DMAC7.html)
KR (1) KR20210089656A (cg-RX-API-DMAC7.html)
CN (1) CN113164761A (cg-RX-API-DMAC7.html)
AU (1) AU2019362753A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021006392A2 (cg-RX-API-DMAC7.html)
CA (1) CA3114672A1 (cg-RX-API-DMAC7.html)
CO (1) CO2021005884A2 (cg-RX-API-DMAC7.html)
IL (1) IL281884A (cg-RX-API-DMAC7.html)
JO (1) JOP20210060A1 (cg-RX-API-DMAC7.html)
MA (1) MA53827A (cg-RX-API-DMAC7.html)
MX (1) MX2021003819A (cg-RX-API-DMAC7.html)
TW (1) TW202024091A (cg-RX-API-DMAC7.html)
UY (1) UY38403A (cg-RX-API-DMAC7.html)
WO (1) WO2020081257A1 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20210060A1 (ar) 2018-10-05 2023-01-30 Vertex Pharma معدلات لمضاد تريبسين ألفا-1
GB201820450D0 (en) 2018-12-14 2019-01-30 Z Factor Ltd Compound and its use for the treatment of alpha1-antitryspin deficiency
US11884672B2 (en) * 2019-05-14 2024-01-30 Vertex Pharmaceuticals Incorporated Modulators of alpha-1 antitrypsin
TW202116303A (zh) * 2019-10-02 2021-05-01 美商維泰克斯製藥公司 α—1抗胰蛋白酶缺乏症之治療方法
GB201918413D0 (en) 2019-12-13 2020-01-29 Z Factor Ltd Compounds and their use for the treatment of alpha1-antitrypsin deficiency
GB201918414D0 (en) 2019-12-13 2020-01-29 Z Factor Ltd Compounds and their use for the treatment of Alpha1-Antitrypsin deficiency
GB201918416D0 (en) 2019-12-13 2020-01-29 Z Factor Ltd Compounds and their use for the treatment of Alpha1-Antitrypsin deficiency
GB201918410D0 (en) 2019-12-13 2020-01-29 Z Factor Ltd Compounds and their use for the treatment of alpha1-antitrypsin deficiency
GB201918404D0 (en) 2019-12-13 2020-01-29 Z Factor Ltd Compounds and their use for the treatment of aplha1-antitrypsin deficiency
AU2021247285A1 (en) 2020-04-03 2022-10-27 Vertex Pharmaceuticals Incorporated Modulators of alpha-1 antitrypsin
CN115697969B (zh) 2020-04-03 2026-08-11 弗特克斯药品有限公司 α-1抗胰蛋白酶调节剂
JP7732999B2 (ja) 2020-04-03 2025-09-02 バーテックス ファーマシューティカルズ インコーポレイテッド アルファ1-アンチトリプシンのモジュレーター
AU2021247282A1 (en) * 2020-04-03 2022-10-27 Vertex Pharmaceuticals Incorporated Modulators of alpha-1 antitrypsin
GB202009074D0 (en) 2020-06-15 2020-07-29 Z Factor Ltd Compound
EP4188931A2 (en) * 2020-07-27 2023-06-07 Vertex Pharmaceuticals Incorporated Processes for preparing modulators of alpha-1 antitrypsin
WO2022104353A1 (en) 2020-11-12 2022-05-19 Vertex Pharmaceuticals Incorporated Methods of monitoring alpha-1 antitrypsin (aat) deficiency by measuring polymerised aat
US20240002386A1 (en) * 2020-11-17 2024-01-04 Vertex Pharmaceuticals Incorporated Solid forms of 4-(5-(4-fluorophenyl)-6-(tetrahydro-2h-pyran-4-yl)-1,5-dihydropyrrolo[2,3-f]indazol-7-yl)benzoic acid
GB202108523D0 (en) 2021-06-15 2021-07-28 Z Factor Ltd Compositions and their use for the treatment of alpha1-antitrypsin deficiency
CN116813623A (zh) * 2022-03-21 2023-09-29 东南大学 一种吡咯并[2,3-f]吲唑类化合物的制备方法
CN114605385B (zh) * 2022-03-25 2023-09-08 河南大学 吲哚哌啶脲类trpv1拮抗/faah抑制双靶点药物及制备方法和应用
WO2025090827A1 (en) 2023-10-27 2025-05-01 Sub21, Inc. A1at modulators
WO2026014456A1 (ja) * 2024-07-10 2026-01-15 株式会社アークメディスン 化合物、補体d因子阻害剤、及び医薬組成物
WO2026136445A1 (en) 2024-12-17 2026-06-25 Sub21, Inc. A1at modulators

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790679A (fr) * 1971-11-03 1973-04-27 Ici Ltd Derives de l'indole
DK158590D0 (da) 1990-07-02 1990-07-02 Lundbeck & Co As H Indolderivater
JP2000072751A (ja) 1998-08-26 2000-03-07 Tanabe Seiyaku Co Ltd イソキノリノン誘導体
JP2000281654A (ja) 1999-03-26 2000-10-10 Tanabe Seiyaku Co Ltd イソキノリン誘導体
GB9913083D0 (en) 1999-06-04 1999-08-04 Novartis Ag Organic compounds
FR2802532A1 (fr) 1999-12-17 2001-06-22 Sanofi Synthelabo Derives de 2-phenyl-quinoleine, leur preparation et leur application en therapeutique
US6638929B2 (en) 1999-12-29 2003-10-28 Wyeth Tricyclic protein kinase inhibitors
CN1452619A (zh) 2000-07-26 2003-10-29 史密斯克莱·比奇曼公司 具有抗细菌活性的氨基哌啶喹啉和它们的氮杂等排的类似物
US20040176361A1 (en) 2001-05-23 2004-09-09 Masakazu Fujio Fused heterocyclic compound and medicinal use thereof
KR20050044450A (ko) 2001-11-14 2005-05-12 테바 파마슈티컬 인더스트리즈 리미티드 로사르탄 칼륨의 무정형 및 결정형 형태 및 이의 제조 방법
US7208601B2 (en) 2003-08-08 2007-04-24 Mjalli Adnan M M Aryl and heteroaryl compounds, compositions, and methods of use
WO2009158587A1 (en) * 2008-06-26 2009-12-30 Inspire Pharmaceuticals, Inc. Method for treating pulmonary diseases using rho kinase inhibitor compounds
WO2011056222A1 (en) 2009-11-05 2011-05-12 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Methods of treating disorders associated with protein aggregation
WO2011110852A1 (en) 2010-03-10 2011-09-15 Astrazeneca Ab Polymorphic forms of 6- [2- (4 -cyanophenyl) - 2h - pyrazol - 3 - yl] - 5 -methyl - 3 - oxo - 4 - (trifluoromethyl - phenyl) 3,4-dihydropyrazine-2-carboxylic acid ethylamide
US9572794B2 (en) 2014-08-06 2017-02-21 Vanderbilt University Substituted indoles as selective protease activated receptor 4 (PAR-4) antagonists
WO2016154051A1 (en) 2015-03-20 2016-09-29 University Of Florida Research Foundation, Inc. Combination therapy for treating infections diseases
CN109414596B (zh) 2016-05-12 2023-09-29 密歇根大学董事会 Ash1l抑制剂和用其进行治疗的方法
CN110546150B (zh) 2017-10-19 2021-12-21 江苏豪森药业集团有限公司 含吡唑基的三并环类衍生物、其制备方法和应用
JP7212693B2 (ja) 2017-11-01 2023-01-25 ブリストル-マイヤーズ スクイブ カンパニー ファルネソイドx受容体モジュレーターとしての架橋二環化合物
CN107698505A (zh) 2017-11-20 2018-02-16 孙婷婷 一种诺得司他的制备方法
CR20200263A (es) 2017-12-13 2020-07-26 Lupin Ltd Componentes heterocíclicos bicíclicos sustituidos como inhibidores de prmt5
CN111971278B (zh) 2018-01-31 2023-08-11 默克专利有限公司 用作irak抑制剂的喹啉化合物及其用途
CA3103920C (en) 2018-06-22 2025-09-16 Ucl Business Ltd COMPOUNDS FOR TREATING DISEASES MEDIATED BY ALPHA-1 ANTITRYPSIN
CA3108388A1 (en) 2018-08-07 2020-02-13 Merck Sharp & Dohme Corp. Prmt5 inhibitors
JOP20210060A1 (ar) 2018-10-05 2023-01-30 Vertex Pharma معدلات لمضاد تريبسين ألفا-1
CN110776459B (zh) 2019-03-19 2023-01-24 江苏知原药业股份有限公司 7-羟基-2-喹诺酮-二硫代氨基甲酸酯类胆碱酯酶抑制剂
US11884672B2 (en) * 2019-05-14 2024-01-30 Vertex Pharmaceuticals Incorporated Modulators of alpha-1 antitrypsin
TW202116303A (zh) 2019-10-02 2021-05-01 美商維泰克斯製藥公司 α—1抗胰蛋白酶缺乏症之治療方法
KR20220133227A (ko) 2020-01-30 2022-10-04 버텍스 파마슈티칼스 인코포레이티드 알파-1 항트립신 결핍증의 치료 방법
CA3177531A1 (en) 2020-04-03 2021-10-07 Vertex Pharmaceuticals Incorporated Indole derivatives as alpha-1 -antitrypsin modulators for treating alpha-1 -antitrypsin deficiency (aatd)
AU2021247282A1 (en) 2020-04-03 2022-10-27 Vertex Pharmaceuticals Incorporated Modulators of alpha-1 antitrypsin
AU2021247285A1 (en) 2020-04-03 2022-10-27 Vertex Pharmaceuticals Incorporated Modulators of alpha-1 antitrypsin
JP7732999B2 (ja) 2020-04-03 2025-09-02 バーテックス ファーマシューティカルズ インコーポレイテッド アルファ1-アンチトリプシンのモジュレーター
WO2021203007A1 (en) 2020-04-03 2021-10-07 Vertex Pharmaceuticals Incorporated Substituted 5-hydroxyindole compounds as modulators of alpha-1 antitrypsin
CN115697969B (zh) 2020-04-03 2026-08-11 弗特克斯药品有限公司 α-1抗胰蛋白酶调节剂
EP4188931A2 (en) 2020-07-27 2023-06-07 Vertex Pharmaceuticals Incorporated Processes for preparing modulators of alpha-1 antitrypsin

Similar Documents

Publication Publication Date Title
RU2328486C2 (ru) Производные 2-пиридона в качестве ингибиторов нейтрофильной эластазы
JP5253696B2 (ja) 抗腫瘍作用を有するインドリル−3−グリオキシル酸誘導体
KR100660309B1 (ko) 시아노페닐 유도체
ATE170856T1 (de) Indolderivate als thromboxane a2 antagonisten
JP2005508336A5 (cg-RX-API-DMAC7.html)
EP1302463A1 (en) Medicine comprising dicyanopyridine derivative
JP2008530099A5 (cg-RX-API-DMAC7.html)
JP2012236838A5 (cg-RX-API-DMAC7.html)
WO2005080384A3 (en) Benzimidazole derivative and use as aii receptor antagonist
HUT68927A (en) Process for producing indoline derivatives and pharmaceutical compositions containing them
CA2654313A1 (en) Aryl-substituted heterobicyclic compounds and their use
KR970703333A (ko) 5-HT_1A 길항제로서의 피페라진 유도체(Piperazine derivatives as 5-HT_1A antagonists)
HUP9903797A2 (hu) Benzofurán-karboxamidok és -szulfonamidok, alkalmazásuk gyógyszerkészítmények előállítására és ezek a gyógyszerkészítmények
JP2023553428A5 (cg-RX-API-DMAC7.html)
JP2025501721A5 (cg-RX-API-DMAC7.html)
JP4268871B2 (ja) ピリミジノン化合物及びその薬剤として許容される塩の製造方法
AU2011901A (en) Substituted n-benzyl-indol-3-yl glyoxylic acid derivatives having an anti-tumoral effect
RU2008105304A (ru) Соединение бензоимидазола, способное к ингибированию простагландин-d-синтетазы
PT620814E (pt) Novas carboxamidas de piperazina
PE20080206A1 (es) Derivados de aril y heteroaril-etil-acilguanidina como inhibidores de renina
AU2013261735B2 (en) Methanethione compounds having antiviral activity
HUT58063A (en) Process for producing 5 ht under 3 antagonist heterocyclic guanidine derivatives
NO20073736L (no) Nye 3-fenylpropionsyrederivater for behandlingen av diabetes
JP2007519685A5 (cg-RX-API-DMAC7.html)
JPS60104064A (ja) イソインドール利尿性誘導体